跳至主要内容
临床试验/JPRN-UMIN000028065
JPRN-UMIN000028065已完成未知

Predictive Value of Genetic Analysis for Pathological Complete Response to Preoperative Treatment in HER2-Positive HR-Negative Early Breast Cancer - PASSION trial

Japan Agency for Medical Research and development0 个研究点目标入组 200 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. Active other malignancies
  • 2. Bilateral breast cance
  • 3. Multicentric tumors
  • 4. History of congestive heart failure or myocardial infarction, arrhythmia or heart valvular disease requiring treatment
  • 5. Clinically significant infection
  • 6. Pregnant or breast-feeding women, women of childbearing potential
  • 7. Diabetes uncontrolled or requiring insulin
  • 8. Systemic sclerosis or systemic lupus erythematosus
  • 9. Systemic use of steroids or immunosuppressive agents
  • 10. Unsuitable mental status for participation
  • 11. Ineligible based on decision of an investigator

研究者

相似试验